Can-Fite BioPharma Ltd.: eps_diluted
| Value | {"per": "shares", "amount": -17.92, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | Can-Fite BioPharma Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:35:01.962698+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/790dacef-e56f-4a45-8e8b-9069e8baa608
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-034447Retrieved: 2026-08-19T15:35:01.962698+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001536196/eps-diluted/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/790dacef-e56f-4a45-8e8b-9069e8baa608
History
- supersedes {"per": "shares", "amount": -0.01, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} (evidence 0001213900-24-026947)